Avanos Medical(AVNS) - 2022 Q4 - Annual Report
Avanos Medical(AVNS)2023-02-20 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to | --- | --- | |-----------------------------------------------------------------------------|-------| | | | | Commission file number: 001-36440 | | | | | | Avan ...